SY
SYRA.US Syra Health Corp. Class A Common Stock
- Market cap
- USD 8.11M
- P/E
- 14.3x
- P/B
- 3.38x
- ROE
- 36.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SYRA.US undervalued?
Graham numberSYRA.US trades 46.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Syra Health Corp. Class A Common Stock fundamental analysis
No fundamental analysis for Syra Health Corp. Class A Common Stock yet.
Syra Health Corp. Class A Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitor…
Full company profileSyra Health Corp. Class A Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Syra Health Corp. Class A Common Stock annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | 1.41M | 5.62M | 5.52M | 7.98M | 7.23M | 9.63M |
| Gross Profit | - | 430K | 1.06M | 1.41M | 1.65M | 2.49M | 4.30M |
| Operating Income | -4.27K | -3.28K | -2.09M | -2.89M | -3.76M | -904K | 990K |
| EBITDA | -4.27K | -3.07K | -2.07M | -2.84M | -3.68M | -863K | 1.06M |
| Net Income | -4.27K | -3.28K | -2.12M | -2.94M | -3.76M | -896K | 1.11M |
| EPS | 0.00 | 0.00 | -0.29 | -0.60 | -0.52 | -0.08 | 0.08 |
| Balance Sheet | |||||||
| Total Assets | 3.00K | 537K | 2.32M | 4.92M | 3.68M | 2.77M | 4.23M |
| Total Liabilities | 7.17K | 544K | 1.61M | 910K | 801K | 675K | 1.20M |
| Shareholders' Equity | -4.17K | -7.15K | 710K | 4.01M | 2.88M | 2.10M | 3.02M |
| Cash & Short-term Investments | 3.00K | 100K | 3.34K | 3.28M | 2.40M | 1.61M | 2.38M |
| Total Debt | 3.00K | 343K | 935K | 248K | 452K | 144K | - |
| Cash Flow | |||||||
| Operating Cash Flow | - | -88.2K | -2.24M | -2.76M | -2.93M | -448K | 1.30M |
| Capital Expenditure | 0.00 | 6.29K | 121K | 15.3K | 11.1K | 107.00 | 13.33 |
| Free Cash Flow | - | -94.5K | -2.37M | -2.77M | -2.94M | -448K | 1.30M |
| Ratios | |||||||
| ROE | - | - | -298.3% | -73.2% | -130.6% | -42.7% | 36.9% |
| ROA | -142.2% | -0.6% | -91.3% | -59.7% | -102.2% | -32.3% | 26.4% |
| Net Profit Margin | - | -0.2% | -37.7% | -53.3% | -47.1% | -12.4% | 11.6% |
| Debt to Equity | - | - | 1.32x | 0.06x | 0.16x | 0.07x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Syra Health Corp. Class A Common Stock dividends
Syra Health Corp. Class A Common Stock has not paid dividends in the last 6 fiscal years.
Who owns Syra Health Corp. Class A Common Stock
- Insiders 51.84%
- Institutions 0.00%
- Public & others 48.16%
- Shares outstanding 13.9M
- Free float 6.74M
Syra Health Corp. Class A Common Stock company profile
- Company name
- Syra Health Corp. Class A Common Stock
- Ticker
- SYRA.US
- Exchange
- USA Stocks
- Listed since
- Sep 29, 2023
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 38
- Fiscal year end
- December
- Address
- 1119 Keystone Way North, Carmel, IN, United States, 46032
- Phone
- 463 345 8950
- Website
- syrahealth.com
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.
Syra Health Corp. Class A Common Stock management
6- Ms. Priya PrasadCFO, COO & Director · born 1978
- Mr. Gregory R. AlexanderChief Executive Officer · born 1969
- Ms. Christine DruryIR/PR, Communications & Marketing Director
- Mr. Jacop LucasSenior Executive Director of People & Operations
- Dr. Cori McMahon PSYDChief Medical Officer
- Feroz SyedPrincipal Stockholder of STLHoldings Corp.